Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.06
0.010.95%
At close: -
$1.06
-0.000100-0.01%
After Hours: Jun 6, 6:22 PM EDT
Comments
Loading...
CytoSorbents Analyst Ratings and Price Targets | NASDAQ:CTSO | Benzinga
CytoSorbents Corp has a consensus price target of $5.6 based on the ratings of 5 analysts. The high is $10 issued by D. Boral Capital on May 15, 2025. The low is $1 issued by HC Wainwright & Co. on May 15, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital, HC Wainwright & Co., and D. Boral Capital on May 15, 2025, May 15, 2025, and May 2, 2025, respectively. With an average price target of $7 between D. Boral Capital, HC Wainwright & Co., and D. Boral Capital, there's an implied 560.44% upside for CytoSorbents Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
HC Wainwright & Co.
EF Hutton
B. Riley Securities
B. Riley Securities
1calculated from analyst ratings
Analyst Ratings for CytoSorbents
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 05/15/2025 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 05/02/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 04/03/2025 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 04/01/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 02/25/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 01/03/2025 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 843.49% | D. Boral Capital | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/11/2024 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 11/08/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/04/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 10/22/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 10/01/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | $10 → $10 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 07/29/2024 | Buy Now | 843.49% | EF Hutton | Jason Kolbert47% | → $10 | Initiates | → Buy | Get Alert |
| 05/15/2024 | Buy Now | 183.05% | B. Riley Securities | Yuan Zhi33% | → $3 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 03/15/2024 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $1 → $1 | Reiterates | Neutral → Neutral | Get Alert |
| 12/29/2023 | Buy Now | -5.65% | HC Wainwright & Co. | Sean Lee62% | $5.5 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 09/07/2023 | Buy Now | 277.39% | B. Riley Securities | Justin Walsh40% | → $4 | Reinstates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 418.92% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | Buy Now | 418.92% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | → Buy | Get Alert |
| 03/10/2023 | Buy Now | 418.92% | HC Wainwright & Co. | Sean Lee62% | → $5.5 | Reiterates | → Buy | Get Alert |
| 11/04/2022 | Buy Now | 418.92% | HC Wainwright & Co. | Sean Lee62% | $9 → $5.5 | Maintains | Buy | Get Alert |
FAQ
What is the target price for CytoSorbents (CTSO) stock?
The latest price target for CytoSorbents (NASDAQ:CTSO) was reported by D. Boral Capital on May 15, 2025. The analyst firm set a price target for $10.00 expecting CTSO to rise to within 12 months (a possible 843.49% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CytoSorbents (CTSO)?
The latest analyst rating for CytoSorbents (NASDAQ:CTSO) was provided by D. Boral Capital, and CytoSorbents maintained their buy rating.
When was the last upgrade for CytoSorbents (CTSO)?
There is no last upgrade for CytoSorbents
When was the last downgrade for CytoSorbents (CTSO)?
The last downgrade for CytoSorbents Corp happened on December 29, 2023 when HC Wainwright & Co. changed their price target from $5.5 to $1 for CytoSorbents Corp.
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating CytoSorbents (CTSO) correct?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a maintained with a price target of $10.00 to $10.00. The current price CytoSorbents (CTSO) is trading at is $1.06, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
